← Back to Search

Speeko for Elderspeak for Dementia

N/A
Waitlist Available
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four app recording sessions per nursing home, through study completion, 1 year.
Awards & highlights

Study Summary

This trial will test an app that detects and reports the use of diminutives, terms of endearment linked to BPSD. The app will demonstrate feasibility and will be tested for preliminary efficacy in a clinical trial.

Eligible Conditions
  • Dementia
  • Staff Attitudes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four app recording sessions per nursing home, through study completion, 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and four app recording sessions per nursing home, through study completion, 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in elderspeak measured by the number of diminutives detected in participant's recorded speech.
Secondary outcome measures
Acceptability as measured by System Usability Scale.
Evaluate the app cost by measuring wages per hour by NH role and costs associated with the Speeko for Elderspeak application.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
The treatment NHs will received immediate feedback from the Speeko App after each recording sessions
Group II: ControlActive Control1 Intervention
The Control NHs will not receive app feedback until all recording sessions are complete.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Speeko for Elderspeak
2021
N/A
~30

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
461 Previous Clinical Trials
169,132 Total Patients Enrolled
9 Trials studying Dementia
2,814 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,089 Total Patients Enrolled
265 Trials studying Dementia
23,623,386 Patients Enrolled for Dementia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does my profile satisfy the criteria for this experiment?

"This trial is searching for 77 candidates with dementia who are between 18 and 99 years of age."

Answered by AI

Are enrollees for this research restricted to individuals aged 18 or above?

"This research is accepting volunteers who are at least 18 years of age and no more than 99."

Answered by AI

Are there any available slots left for participants in this research?

"Evidenced on clinicaltrials.gov, the search for participants is still active in this study which was initially publicised on December 9th 2021 and subsequently updated a few months ago, March 14th 2022."

Answered by AI

What is the census of participants in this medical experiment?

"Indeed, clinicaltrials.gov confirms that this medical investigation is actively enrolling patients since its inception on December 9th 2021 and most recent update on March 14th 2022. 77 people will be recruited from one single centre for the trial."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Speeko for Elderspeak
2021. "Speeko for Elderspeak". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04064164.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top